Ikuko Aiba

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy

Keiko Mori, Masahiro Iijima, Haruki Koike et al. · Brain · 2005 · 533 citations · Full text

Painful Sensory Neuropathy, Rheumatology, Autoimmune Disease +12

Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?

Yoshihiko Horimoto, Ikuko Aiba, Takeshi Yasuda et al. · Journal of Neurology · 2002 · 139 citations

Longitudinal Mri Study, Imaging Anatomy, Neurological Disorder +7

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Tien Dam, Adam L. Boxer, Lawrence I. Golbe et al. · Nature Medicine · 2021 · 131 citations

Rheumatology, Progressive Supranuclear Palsy, Placebo-controlled Trial +3

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 130 citations · Full text

Clinical Trials, Progressive Supranuclear Palsy, Placebo-controlled Trial +7